Cimzia®
Cimzia (certolizumab pegol) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells helping to protect healthy cells from damage. Specifically it is a tumor necrosis factor blocker (TNF) for treatment of Crohn’s Disease Rheumatoid Arthritis (RA) Psoriatic Arthritis Ankylosing Spondylitis Non-radiographic Axial Spondylarthritis.
For more information, visit the patient website for this drug.
Speak with your healthcare provider to learn if this drug is right for you.
MANUFACTURER: UCB Group |
CLASS: Biologics (tumor necrosis factor blocker) |
WHAT IT TREATS:
|
PRESCRIBED BY:
|
HOW ADMINISTERED: Subcutaneous injection |
FREQUENCY: Initial dose then two weeks later then 4 weeks and every 4 weeks after |
Length of infusion: About 15 minutes |
FOR MORE INFORMATION: |
